217 related articles for article (PubMed ID: 29455649)
1. Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.
Zhao L; Fong AHW; Liu N; Cho WCS
J Biomed Sci; 2018 Feb; 25(1):16. PubMed ID: 29455649
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma.
Yue PY; Ha WY; Lau CC; Cheung FM; Lee AW; Ng WT; Ngan RK; Yau CC; Kwong DL; Lung HL; Mak NK; Lung ML; Wong RN
Sci Rep; 2017 Sep; 7(1):12012. PubMed ID: 28931826
[TBL] [Abstract][Full Text] [Related]
4. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
5. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
6. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4.
Jiang C; Wang H; Zhou L; Jiang T; Xu Y; Xia L
Oncol Rep; 2017 Jul; 38(1):82-88. PubMed ID: 28504814
[TBL] [Abstract][Full Text] [Related]
8. Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning.
Zhang X; Li X; Wang C; Wang S; Zhuang Y; Liu B; Lian X
Front Endocrinol (Lausanne); 2023; 14():1174911. PubMed ID: 37538797
[TBL] [Abstract][Full Text] [Related]
9. microRNA expression profiling of nasopharyngeal carcinoma.
Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
[TBL] [Abstract][Full Text] [Related]
10. hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis.
Su B; Xu T; Bruce JP; Yip KW; Zhang N; Huang Z; Zhang G; Liu FF; Liang J; Yang H; Claret FX
Oncol Rep; 2018 Nov; 40(5):2536-2546. PubMed ID: 30226609
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma.
Luan J; Wang J; Su Q; Chen X; Jiang G; Xu X
Oncotarget; 2016 Mar; 7(9):10513-21. PubMed ID: 26824418
[TBL] [Abstract][Full Text] [Related]
12. miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1.
Li Y; Chen X
Biochem Biophys Res Commun; 2015 Dec; 468(4):863-9. PubMed ID: 26585487
[TBL] [Abstract][Full Text] [Related]
13. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
14. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
15. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
16. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
17. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
Liu Z; Wu K; Yang Z; Wu A
Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation Through Targeting Interleukin-17.
Wang LX; Kang ZP; Yang ZC; Ma RX; Tan Y; Peng XB; Dai RZ; Li J; Yu Y; Xu M
Cell Physiol Biochem; 2018; 46(6):2232-2238. PubMed ID: 29734196
[TBL] [Abstract][Full Text] [Related]
20. Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.
Wang HY; Yan LX; Shao Q; Fu S; Zhang ZC; Ye W; Zeng YX; Shao JY
Clin Chem; 2014 May; 60(5):773-82. PubMed ID: 24563490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
